Literature DB >> 24403352

Cardiac catheter procedures during extracorporeal life support: a risk-benefit analysis.

Biswa R Panda1, Nelson Alphonso, Maheshkumar Govindasamy, Benjamin Anderson, Christian Stocker, Tom R Karl.   

Abstract

BACKGROUND: Extracorporeal life support (ECLS) is a valuable tool for situations in which cardiac disease acutely threatens the life of a child. Residual anatomic lesions have a strong negative influence on survival when ECLS is used after cardiac operations. Accurate diagnostic information is essential, and although noninvasive studies are preferred (eg, echocardiography and thoracic computed tomographic angiography), they are not always logistically practical nor adequate in complex situations under the loading and nonpulsatile flow conditions of ECLS.
METHODS: We analyzed our experience (February 2009 to August 2012) with cardiac ECLS for 59 children. Of the 59 children, 22 (median age and weight 19.5 days and 4 kg) with advanced cardiac dysfunction had catheter studies performed during support.
RESULTS: The 22 patients had 28 studies, without major adverse events relating to the procedure or transport. Problems leading to further therapeutic procedures (catheter based seven, hybrid two, or surgical eight) were discovered in 17 of the 22 patients. For 22 catheterized patients, total time on ECLS, weaning probability, and survival to discharge were 151.6 ± 122.6 hours, 81%, and 68%, respectively, similar to that for the 37 cardiac support patients not requiring catheter studies during support (P = 0.94, 0.37, and 0.59, respectively).
CONCLUSION: Assuming that undiscovered anatomic and/or hemodynamic issues would have had a strong negative influence on survival, we may conclude that the risk-benefit ratio was positive and favorable. Catheter studies during ECLS are safe and should be performed expeditiously when diagnostic questions cannot be resolved by noninvasive means.

Entities:  

Keywords:  ECMO; cardiac catheterization

Mesh:

Year:  2014        PMID: 24403352     DOI: 10.1177/2150135113505297

Source DB:  PubMed          Journal:  World J Pediatr Congenit Heart Surg        ISSN: 2150-1351


  7 in total

1.  Cardiac Catheterization in Pediatric Patients Supported by Extracorporeal Membrane Oxygenation: A 15-Year Experience.

Authors:  Nicholas S Boscamp; Mariel E Turner; Matthew Crystal; Brett Anderson; Julie A Vincent; Alejandro J Torres
Journal:  Pediatr Cardiol       Date:  2016-11-21       Impact factor: 1.655

2.  Outcomes of pediatric patients undergoing cardiac catheterization while on extracorporeal membrane oxygenation.

Authors:  Ryan Callahan; Sara M Trucco; Peter D Wearden; Lee B Beerman; Gaurav Arora; Jacqueline Kreutzer
Journal:  Pediatr Cardiol       Date:  2014-11-09       Impact factor: 1.655

3.  Cardiac catheterization procedures in pediatric patients undergoing extracorporeal membrane oxygenation cardiac catheterization, ECMO.

Authors:  Alper Güzeltaş; Taner Kasar; İbrahim Cansaran Tanıdır; Erkut Öztürk; Okan Yıldız; Sertaç Haydin
Journal:  Anatol J Cardiol       Date:  2017-12       Impact factor: 1.596

4.  ECMO in children post cardiac surgery-opportunity for redress.

Authors:  Mazeni Alwi
Journal:  Anatol J Cardiol       Date:  2017-12       Impact factor: 1.596

5.  ECMO support in cardiac intervention of severe pulmonary stenosis: A case report.

Authors:  Xiang Yu; Rong-Hua Zhou
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

6.  Cardiac Catheterization in the Early Post-Operative Period after Congenital Heart Surgery.

Authors:  Taner Kasar; Ibrahim Cansaran Tanidir; Erkut Ozturk; Candas Kafali; Murat Sahin; Okan Yildiz; Sertac Haydin; Alper Guzeltas
Journal:  Acta Cardiol Sin       Date:  2018-11       Impact factor: 2.672

7.  The utility of computed tomographic angiography in a neonate on extracorporeal membrane oxygenation with extreme cyanosis after Blalock-Taussig shunt.

Authors:  Jess D Rames; Minoo N Kavarana; U Joseph Schoepf; Anthony Marcus Hlavacek
Journal:  Ann Pediatr Cardiol       Date:  2017 May-Aug
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.